Edward P. Armstrong

Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Amanda Harrington, Edward P. Armstrong, Paul E. Nolan et al. · Stroke · 2013 · 259 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality

Prasadini Perera, Edward P. Armstrong, Duane L. Sherrill et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2012 · 212 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Concordance of Severity Ratings Provided in Four Drug Interaction Compendia

Jacob Abarca, Daniel C. Malone, Edward P. Armstrong et al. · Journal of the American Pharmacists Association · 2004 · 208 citations

Pharmacy, Pharmacology, Drug Interactions +13

Identification of Serious Drug–Drug Interactions: Results of the Partnership to Prevent Drug–Drug Interactions

Daniel C. Malone, Edward P. Armstrong, Jacob Abarca et al. · Journal of the American Pharmacists Association · 2004 · 191 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Clinical and Economic Analysis of Methicillin-Susceptible and -Resistant <i>Staphylococcus aureus</i> Infections

Brian J. Kopp, David E. Nix, Edward P. Armstrong · Annals of Pharmacotherapy · 2004 · 138 citations

Pharmacy, Infectious Diseases, Pharmacoeconomics +13